Method of inducing and/or enhancing an immune response to tumor antigens
US8017590B1 · kind B1 · utility
15Cited by
66References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2000 |
| Grant date | Sep 13, 2011 |
| Priority date | — |
| Expiry date | Oct 20, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/24071
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An improved method of inducing and/or enhancing an immune response to a tumor antigen is disclosed. The method involves administering the tumor antigen, nucleic acid coding therefor, vectors and/or cells comprising said nucleic acid, or vaccines comprising the aforementioned to a lymphatic site.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.